scholarly article | Q13442814 |
P50 | author | Douglas E. Williams | Q111326907 |
Stewart D. Lyman | Q111337179 | ||
Hilary J. McKenna | Q111337352 | ||
P2093 | author name string | Lee CC | |
Morris AE | |||
Morrissey PJ | |||
Brasel K | |||
Charrier K | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2004-2012 | |
P577 | publication date | 1996-09-01 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Hematologic effects of flt3 ligand in vivo in mice | |
P478 | volume | 88 |
Q36983731 | A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration |
Q58096557 | AAV-Vectored Fms-Related Tyrosine Kinase 3 Ligand Inhibits CD34 Progenitor Cell Engraftment in Humanized Mice |
Q36026031 | Allergic airway inflammation |
Q34602386 | Antigen-stimulated CD4 T-cell expansion is inversely and log-linearly related to precursor number. |
Q33907236 | Attenuation of vaccinia virus by the expression of human Flt3 ligand |
Q33749336 | Bone marrow transplantation temporarily improves pancreatic function in streptozotocin-induced diabetes: potential involvement of very small embryonic-like cells. |
Q36319530 | CD26 protease inhibition improves functional response of unfractionated cord blood, bone marrow, and mobilized peripheral blood cells to CXCL12/SDF-1. |
Q37234292 | CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation |
Q34089167 | Classical Flt3L-dependent dendritic cells control immunity to protein vaccine |
Q33887809 | Control of B cell development by Ras-mediated activation of Raf. |
Q36607055 | Coxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors |
Q90069593 | Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche |
Q37590337 | Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines |
Q39278063 | Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae |
Q41832921 | Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity |
Q36367631 | Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified |
Q28583154 | Effect of Flt3 ligand gene transfer in experimental pancreatic cancer |
Q34626662 | Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis |
Q43289248 | Expression, purification and characterization of the extracellular domain of human Flt3 ligand in Escherichia coli |
Q38759255 | FLT3 ligand regulates thymic precursor cells and hematopoietic stem cells through interactions with CXCR4 and the marrow niche |
Q37619537 | FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcome. |
Q38497229 | Fate mapping of dendritic cells |
Q34973744 | Flt3 does not play a critical role in murine myeloid leukemias induced by MLL fusion genes |
Q36371293 | Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo |
Q58778314 | Flt3 ligand treatment reduces enterovirus A71 lethality in mice with enhanced B cell responses |
Q42739962 | Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administration |
Q34541467 | Immune therapy for breast cancer in 2010-hype or hope? |
Q33856002 | Immunotherapeutic approaches for the treatment of breast cancer |
Q42326966 | Improved bicistronic mammalian expression vectors using expression augmenting sequence element (EASE). |
Q36618076 | In vitro culture during retroviral transduction improves thymic repopulation and output after total body irradiation and autologous peripheral blood progenitor cell transplantation in rhesus macaques |
Q34076517 | In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis |
Q36943742 | Increased expression of CCL2 in insulin-producing cells of transgenic mice promotes mobilization of myeloid cells from the bone marrow, marked insulitis, and diabetes |
Q38035032 | Innate immunity and the regulation and mobilization of keratinocyte stem cells: are the old players playing a new game? |
Q34309830 | Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives. |
Q39917950 | Isolation, characterization and recombinant protein expression in Veggie-CHO: A serum-free CHO host cell line |
Q34453798 | LAMTOR2 regulates dendritic cell homeostasis through FLT3-dependent mTOR signalling |
Q36745048 | Leukemia-associated activating mutation of Flt3 expands dendritic cells and alters T cell responses |
Q36275693 | Maturation of function in dendritic cells for tolerance and immunity. |
Q89558892 | Mobilized peripheral blood: an updated perspective |
Q73196801 | Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties |
Q36369285 | Neonatally induced inactivation of the vascular cell adhesion molecule 1 gene impairs B cell localization and T cell-dependent humoral immune response |
Q24607533 | Novel vaccine development strategies for inducing mucosal immunity |
Q28592017 | Parathyroid hormone mediates hematopoietic cell expansion through interleukin-6 |
Q73147768 | Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant |
Q33811836 | Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment |
Q48219588 | Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents. |
Q35604052 | Quantitative trait mapping reveals a regulatory axis involving peroxisome proliferator-activated receptors, PRDM16, transforming growth factor-β2 and FLT3 in hematopoiesis |
Q24598872 | RANK is essential for osteoclast and lymph node development |
Q34607733 | RNA sequencing and transcriptomal analysis of human monocyte to macrophage differentiation |
Q45737807 | Reduced herpes simplex virus type 1 latency in Flt-3 ligand-treated mice is associated with enhanced numbers of natural killer and dendritic cells |
Q42229089 | Selective Expression of Flt3 within the Mouse Hematopoietic Stem Cell Compartment. |
Q39607848 | Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo. |
Q25256900 | Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer |
Q48197487 | Serum Cytokine Profiling in Cats with Acute Idiopathic Cystitis |
Q46705750 | Serum FLT-3 ligand in a busulphan-induced model of chronic bone marrow hypoplasia in the female CD-1 mouse |
Q35011710 | Stimulation of hematopoiesis by the Fms-like tyrosine kinase 3 ligand restores bacterial induction of Th1 cytokines in thermally injured mice |
Q34910186 | Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus |
Q46821465 | The haemotoxicity of mitomycin in a repeat dose study in the female CD-1 mouse |
Q64917514 | The potential of non-myeloablative heterochronous autologous hematopoietic stem cell transplantation for extending a healthy life span. |
Q28510383 | The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues |
Q78157743 | Visualizing the T-cell response elicited by oral administration of soluble protein antigen |
Search more.